6/30/2014 9:15:55 AM
SAN DIEGO--(BUSINESS WIRE)--La Jolla Pharmaceutical Company (Nasdaq: LJPC) (the “Company” or “La Jolla”), a leader in the development of therapeutics targeting significant unmet life-threatening diseases, today announced that the Company was added to the Russell Microcap Index when Russell Investments reconstituted its comprehensive set of U.S. and global equity indices on June 27.
“We have been working diligently to develop novel therapies for unmet medical needs,” said George Tidmarsh, Chief Executive Officer of La Jolla Pharmaceutical Company. “We expect inclusion in the Russell Microcap Index will increase the liquidity of our stock and expose us to a wide range of institutions, investors, and index funds that reference them.”
Help employers find you! Check out all the jobs and post your resume.
comments powered by